Roble Belko & Company’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24K | Hold |
218
| – | – | ﹤0.01% | 225 |
|
|
2025
Q1 | $24K | Hold |
218
| – | – | ﹤0.01% | 211 |
|
|
2024
Q4 | $20K | Hold |
218
| – | – | ﹤0.01% | 216 |
|
|
2024
Q3 | $18K | Hold |
218
| – | – | ﹤0.01% | 209 |
|
|
2024
Q2 | $15K | Hold |
218
| – | – | ﹤0.01% | 223 |
|
|
2024
Q1 | $16K | Hold |
218
| – | – | ﹤0.01% | 228 |
|
|
2023
Q4 | $18K | Hold |
218
| – | – | ﹤0.01% | 209 |
|
|
2023
Q3 | $16K | Hold |
218
| – | – | ﹤0.01% | 192 |
|
|
2023
Q2 | $17K | Hold |
218
| – | – | ﹤0.01% | 192 |
|
|
2023
Q1 | $18K | Hold |
218
| – | – | ﹤0.01% | 203 |
|
|
2022
Q4 | $19K | Buy |
+218
| New | +$19K | ﹤0.01% | 216 |
|
|
2017
Q3 | – | Sell |
-235
| Closed | -$17K | – | 296 |
|
|
2017
Q2 | $17K | Sell |
235
-82
| -26% | -$5.93K | 0.01% | 149 |
|
|
2017
Q1 | $22K | Sell |
317
-625
| -66% | -$43.4K | 0.01% | 136 |
|
|
2016
Q4 | $67K | Sell |
942
-663
| -41% | -$47.2K | 0.04% | 87 |
|
|
2016
Q3 | $127K | Buy |
1,605
+266
| +20% | +$21K | 0.07% | 63 |
|
|
2016
Q2 | $112K | Buy |
1,339
+1,035
| +340% | +$86.6K | 0.06% | 70 |
|
|
2016
Q1 | $28K | Buy |
304
+204
| +204% | +$18.8K | 0.02% | 117 |
|
|
2015
Q4 | $10K | Hold |
100
| – | – | 0.01% | 146 |
|
|
2015
Q3 | $10K | Hold |
100
| – | – | 0.01% | 139 |
|
|
2015
Q2 | $12K | Buy |
+100
| New | +$12K | 0.01% | 149 |
|